Analgesic effect of subarachnoid neostigmine in two patients with cancer pain

Pain

Volumn 66, Issue 2-3, 1996, Pages 389-391

  Klamt, Jyrson G ^a   Dos Reis, Marlene P ^a   Neto, José Barbieri ^a   Prado, Wiliam A ^b  

^a and T ^*  (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Analgesia; Chronic pain; Neostigmine

Indexed keywords

NEOSTIGMINE;

ADULT; ANALGESIC ACTIVITY; ARTICLE; CANCER PAIN; CASE REPORT; CHRONIC PAIN; DRUG EFFECT; DRUG EFFICACY; HUMAN; MALE; PRIORITY JOURNAL; SPINAL ANESTHESIA;

EID: 0030220597     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-3959(96)03045-X     Document Type: Article

References (18)

1. Benedetti, C. and Butler, S.H., Systemic analgesics. In: J.J. Bonica (Ed.), The Management of Pain, 2nd edn., Lea and Febiger, Philadelphia, PA, 1990, pp. 1640-1675.
2. Dirksen R., Nijhuis G.M.H. The relevance of cholinergic transmission at the spinal level to opiate effectiveness. Eur. J. Pharmacol. 91:1983;215-225.
3. Eisenach J.C., Tong C., Hood D.D. Pharmacokinetics of spinal neostigmine in humans. Anesthesiology. 81:1994;26.
4. Gillberg P.G., Gordh T. Jr., Hartvig P., Jansson I., Pettersson J., Post C. Characterization of the antinociception induced by intrathecally administered carbachol. Pharmacol. Toxicol. 64:1989;340-343.
5. Gordh T. Jr., Jansson I., Hartvig P., Gillberg P.G., Post C. Interactions between noradrenergic and cholinergic mechanisms involved in spinal nociceptive processing. Acta Anesthesiol. Scand. 33:1989;39-47.
6. Green P.G., Kitchen I. Antinociception opioids and the cholinergic system. Prog. Neurobiol. 26:1986;119-146.
7. Hood D.D., Eisenach J.C. Phase I safety assessment of spinal neostigmine in volunteers. Anesthesiology. 81:1994;26.
8. Hood D.D., Eisenach J.C. Side effects and analgesia from spinal neostigmine injected through a Whitacre needle. Anesthesiology. 81:1994;27.
9. Hood D.D., Eisenach J.C. The hemodynamic and spinal cord blood flow effects of intrathecal neostigmine in sheep. Anesthesiology. 81:1994;27.
10. Pettersson J., Gordh T. Jr., Hartvig P., Wiklund L. A double-blind trial of the analgesic properties of physostigmine in postoperative patients. Acta Anaesthesiol. Scand. 30:1986;283-288.
11. Schott G.D., Loh L. Anticholinesterase drugs in the treatment of chronic pain. Pain. 20:1984;201-206.
12. Smith M.D., Yang X., Nha J.Y., Boccafusco J.I. Antinociceptive effect of spinal cholinergic stimulation: interaction with substance P. Life Sci. 45:1989;1255-1261.
13. Snir-Mor I., Weinstock M., Davidson J.T., Bahar M. Physostigmine antagonizes morphine-induced respiratory depression in human subjects. Anesthesiology. 59:1983;6-9.
14. Taylor, P., Anticholinesterase agents. In: A.J. Gilman, L.S. Goodman and T.W. Rall (Eds.), The Pharmacological Basis of Therapeutics, 7th edn., Pergamon Press, New York, 1985a, pp. 110-129.
15. Taylor, P., Neuromuscular blocking agents. In: A.J. Gilman, L.S. Goodman and T.W. Rall (Eds.), The Pharmacologial Basis of Therapeutics, 7th edn., Pergamon Press, New York, 1985b, pp. 222-235.
16. Weinstock M., Davidson J.T., Robin A.J., Scheiden A. Effect of physostigmine on morphine-induced postoperative pain and somnolence. Br. J. Anaesth. 54:1982;4229-4243.
17. Williams S., Chuanyao T., Eisenach J.C. Neostigmine counteracts spinal clonidine-induced hypotension in sheep. Anesthesiology. 78:1993;301-307.
18. Yaksh T.L., Dirksen R., Harty G.J. Antinociceptive effects of intrathecally injected cholinomimetic drugs in the rat and cat. Eur. J. Pharmacol. 117:1985;81-88.